Literature DB >> 18646491

Component structure of the SF-36 in Jamaicans with sickle cell disease.

M Asnani1, G Lipps, M Reid.   

Abstract

OBJECTIVES: Sickle cell disease (SCD) is the commonest genetic disorder in Jamaica and greatly affects the quality of life (QOL) of those who are afflicted. The Short Form 36 survey (SF-36) questionnaire is one of the most commonly utilized measures of QOL. Physicians cannot interpret QOL measures until the instruments being used to make assessment are adequately established in their population. The Jamaican cultural and educational systems expose its people to many stresses which likely impact on their QOL. It is thus postulated that the QOL construct may exhibit a different structure for the population with sickle cell disease. SUBJECTS AND METHODS: The SF-36 v.2 was interviewer administered to the Jamaican Sickle Cell Disease Cohort Study participants ('Cohort' sample) and a random sample of adult sickle cell unit patients ('Main'sample). Demographic data were also collected on both groups. Both of the samples did not meet the five rule criteria for compliance with the original SF-36 component structure. Hence, principal components analysis was used to determine the component structure of the SF-36 in both groups.
RESULTS: Three dimensions may underlie the SF-36 for both groups and these could be labelled 'Physical Health', 'Mental Health' and 'Role Limitations'. This solution accounted for 45.8% of the variability underlying the SF-36 in the 'Cohort'sample and 54.6% of the variability in the 'Main' sample.
CONCLUSIONS: It concluded that within Jamaican samples of patients with sickle cell disease, the SF-36 has a component structure which is quite distinct from that initially proposed by its creators.

Entities:  

Mesh:

Year:  2007        PMID: 18646491

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  7 in total

1.  Utility of WHOQOL-BREF in measuring quality of life in sickle cell disease.

Authors:  Monika R Asnani; Garth E Lipps; Marvin E Reid
Journal:  Health Qual Life Outcomes       Date:  2009-08-10       Impact factor: 3.186

2.  Adult sickle cell quality-of-life measurement information system (ASCQ-Me): conceptual model based on review of the literature and formative research.

Authors:  Marsha J Treadwell; Kathryn Hassell; Roger Levine; San Keller
Journal:  Clin J Pain       Date:  2014-10       Impact factor: 3.442

3.  Translation, cross-cultural adaptation and psychometric evaluation of yoruba version of the short-form 36 health survey.

Authors:  Chidozie Emmanuel Mbada; Gafar Atanda Adeogun; Michael Opeoluwa Ogunlana; Rufus Adesoji Adedoyin; Adesanmi Akinsulore; Taofeek Oluwole Awotidebe; Opeyemi Ayodiipo Idowu; Olumide Ayoola Olaoye
Journal:  Health Qual Life Outcomes       Date:  2015-09-14       Impact factor: 3.186

4.  Preference-based measure of health-related quality of life and its determinants in sickle cell disease in Nigeria.

Authors:  Adedokun Oluwafemi Ojelabi; Afolabi Elijah Bamgboye; Jonathan Ling
Journal:  PLoS One       Date:  2019-11-18       Impact factor: 3.240

5.  Health-Related Quality of Life Among Patients With Sickle Cell Disease in an Adult Hematology Clinic in a Tertiary Hospital in Lagos, Nigeria.

Authors:  Lemchukwu Amaeshi; Olufunto O Kalejaiye; Chibuzor F Ogamba; Folasade Adelekan Popoola; Yusuf A Adelabu; Chibuikem A Ikwuegbuenyi; Ijeoma B Nwankwo; Oluwademilade Adeniran; Michael Imeh; Michael O Kehinde
Journal:  Cureus       Date:  2022-01-18

6.  Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective.

Authors:  Francesca Rodigari; Giorgia Brugnera; Raffaella Colombatti
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

7.  Black sickle cell patients' lives matter: healthcare, long-term shielding and psychological distress during a racialised pandemic in England - a mixed-methods study.

Authors:  Maria J Berghs; Francesca Horne; Scott Yates; Sadeh Graham; Rachel Kemp; Amy Webster; Carlton Howson
Journal:  BMJ Open       Date:  2022-09-23       Impact factor: 3.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.